| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |